ArticleTumori2020

Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience.

Eufemia S Lutrino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.